Prosecution Insights
Last updated: October 02, 2026
Application No. 18/720,964

Surface Adjuster for Zinc Phosphate Chemical Conversion Treatment

Non-Final OA §103§112
Filed
Jun 17, 2024
Priority
Dec 27, 2021 — JP 2021-212058 +1 more
Examiner
ABU ALI, SHUANGYI
Art Unit
Tech Center
Assignee
Nihon Parkerizing Co., Ltd.
OA Round
1 (Non-Final)
45%
Grant Probability
Moderate
1-2
OA Rounds
1y 10m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 45% of resolved cases
45%
Career Allowance Rate
487 granted / 1074 resolved
-14.7% vs TC avg
Strong +38% interview lift
Without
With
+37.8%
Interview Lift
resolved cases with interview
Typical timeline
4y 1m
Avg Prosecution
52 currently pending
Career history
1127
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
56.2%
+16.2% vs TC avg
§102
12.8%
-27.2% vs TC avg
§112
20.3%
-19.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1074 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I, claims 1-2 in the reply filed on 08/19/2026 is acknowledged. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 2 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The term “substantially no” in claim 2 is a relative term which renders the claim indefinite. The term “substantially no” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-2 is/are rejected under 35 U.S.C. 103 as being unpatentable over CN108728836A. Regarding claim 1, CN108728836A discloses a composition comprising a composition comprising zinc dihydrogen phosphate, a copolymer containing a 2-acrylamide-2-methylpropane sulfonic acid unit, such as acrylic 2-acrylamide-2-methylpropane sulfonic acid, sodium silicate (alkali salt is added) and water. See [0008] and [0013]. It is known in the art that the copolymer composition typically ranges from 35–90 mol% acrylic acid and 10–65 mol% AMPS. When the mole content is converted to mass percentage, the mass content of AMPS overlaps with the claimed “a ratio of (b1) in the copolymer (b2) is 7.5% by mass to 40.0% by mass”. The reference differs from Applicant's recitations of claims by not disclosing identical ranges. However, the reference discloses "overlapping" ranges, and overlapping ranges have been held to establish prima facie obviousness (MPEP 2144.05). A recitation of the intended use of the claimed invention must result in a structural difference between the claimed invention and the prior art in order to patentably distinguish the claimed invention from the prior art. If the prior art structure is capable of performing the intended use, then it meets the claim. Regarding claim 2, the composition comprises no hectorite. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHUANGYI ABU ALI whose telephone number is (571)272-6453. The examiner can normally be reached Monday - Friday, 8:00 am- 5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Amber Orlando can be reached at (571)270-3149. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SHUANGYI ABU ALI/ Primary Examiner, Art Unit 1731
Read full office action

Prosecution Timeline

Jun 17, 2024
Application Filed
Sep 21, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12735556
FABRICATION OF BENZOXAZINE FUNCTIONALIZED PARTICLES
4y 2m to grant Granted Sep 15, 2026
Patent 12709549
CERIUM BASED PARTICLES, PROCESS FOR PRODUCING THE SAME AND USES THEREOF IN POLISHING
4y 2m to grant Granted Aug 18, 2026
Patent 12703663
BIO-CATALYTIC CALCIUM CARBONATE CEMENTATION
7y 7m to grant Granted Aug 11, 2026
Patent 12703664
NANOPOROUS CERAMIC FOR ATOMIZATION CORE AND PREPARATION METHOD THEREOF
3y 1m to grant Granted Aug 11, 2026
Patent 12698237
BUILDING MATERIALS AND COMPONENTS AND METHODS OF MAKING THE SAME
2y 6m to grant Granted Aug 04, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
45%
Grant Probability
83%
With Interview (+37.8%)
4y 1m (~1y 10m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1074 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month